Thursday - April 25, 2024

Primary Sclerosing Cholangitis Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

Cutaneous T-Cell Lymphoma (CTCL) Market Size was USD 520 million in 2023, estimates DelveInsight | 4SC, Bio-Path Holdings, BioInvent International, Bioniz Therapeutics, Citius Pharmaceuticals, Roche

Cutaneous T-Cell Lymphoma Market Cutaneous T-Cell Lymphoma (CTCL) Companies are 4SC, Bio-Path Holdings, BioInvent International AB, Bioniz Therapeutics, Citius Pharmaceuticals, Codiak BioSciences, Elorac, Equillium, Genzada Pharmaceuticals, Hoffmann-La Roche, Innate Pharma, Jiangsu Simcere Pharmaceutical, Kymera Therapeutics, Legend Biotech, Merck Sharp & … Continue reading

Pompe Disease Market to witness growth by 2032, estimates DelveInsight | Spark Therapeutics, Amicus Therapeutics, Asklepios Biopharmaceutical, Audentes Therapeutics, Rocket Pharmaceuticals, Avidity

Pompe Disease Market Pompe Disease companies are Spark Therapeutics, Amicus Therapeutics, Asklepios Biopharmaceutical, Audentes Therapeutics, Rocket Pharmaceuticals, Avidity Biosciences, AVROBIO, Maze Therapeutics, Denali Therapeutics, Novartis, Fresenius Kabi AG, Akorn Incorporated, Teva Pharmaceutical, Mylan N.V, Johnsons & Johnsons, F. Hoffman-La Roche, … Continue reading

Multiple Myeloma Market size was USD 21,300 million in 2023, estimates DelveInsight | GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Pfizer, more

Multiple Myeloma Market Multiple Myeloma companies are GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Millennium Pharmaceuticals, Sanofi, Karyopharm Therapeutic, Janssen Biotech, AbbVie, RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Aduro Biotech, ExCellThera, Precision BioSciences, Takeda, … Continue reading

Crohn’s Disease Pipeline Assessment 2024: Clinical Trials, FDA, EMA, PDMA Approvals, Therapies, Treatment Market, Mechanism of Action, Route of Administration by DelveInsight

Crohn’s Disease Pipeline As per DelveInsight’s assessment, globally, Crohn’s Disease pipeline constitutes 70+ key companies continuously working towards developing 75+ Crohn’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. (New … Continue reading